Genocea Biosciences Inc
NASDAQ:GNCA
Genocea Biosciences Inc
Revenue
Genocea Biosciences Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Genocea Biosciences Inc
NASDAQ:GNCA
|
Revenue
$1.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$29.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
19%
|
Genocea Biosciences Inc
Revenue Breakdown
Breakdown by Geography
Genocea Biosciences Inc
Breakdown by Segments
Genocea Biosciences Inc
Total Revenue:
1.6m
USD
|
Material Transfer Agreement:
1.6m
USD
|
See Also
What is Genocea Biosciences Inc's Revenue?
Revenue
1.6m
USD
Based on the financial report for Dec 31, 2021, Genocea Biosciences Inc's Revenue amounts to 1.6m USD.
What is Genocea Biosciences Inc's Revenue growth rate?
Revenue CAGR 5Y
48%
Over the last year, the Revenue growth was 21%.